Understanding Causes Of The Rising Incidence Of Thyroid Cancer – What Can Mutations In The BRAF Oncogene Tell Us About Causes And Diagnostic Pathways For Thyroid Cancer?
Funder
National Health and Medical Research Council
Funding Amount
$610,222.00
Summary
The occurrence of thyroid cancer has increased rapidly over the last 25 years but the cause is unknown. The increase may reflect ‘over-diagnosis’ of less harmful cancers or greater exposure to causes of this cancer. Evidence suggests that a gene mutation (BRAF) in thyroid cancers is important in understanding the drivers of the increase. This study will examine the increase in thyroid cancer by investigating causes and diagnostic pathways considering the presence or absence of BRAF mutations.
Exploiting SNP Data In Epidemiology And Genetics Through Multivariate Analysis Of Complex Traits
Funder
National Health and Medical Research Council
Funding Amount
$476,981.00
Summary
There is overlap in risk factors across multiple diseases, and some of that overlap is due to genetic factors. The availability of genome-wide DNA data on tens of thousands of patients for multiple diseases and healthy controls allows new questions to be asked and answered. For example, what is the overlap due to genes in disease risk for multiple sclerosis and rheumatoid arthritis? This project will develop and statistical genetic methodology to answer such questions and apply those methods to ....There is overlap in risk factors across multiple diseases, and some of that overlap is due to genetic factors. The availability of genome-wide DNA data on tens of thousands of patients for multiple diseases and healthy controls allows new questions to be asked and answered. For example, what is the overlap due to genes in disease risk for multiple sclerosis and rheumatoid arthritis? This project will develop and statistical genetic methodology to answer such questions and apply those methods to a range of important diseases.Read moreRead less
Genetic Epidemiology Of Endometrial Cancer: Towards Understanding Aetiology And Improving Risk Prediction.
Funder
National Health and Medical Research Council
Funding Amount
$353,573.00
Summary
Studies investigating thousands of genetic markers have revolutionised our understanding of genes involved in cancer, and shown that a single gene can be associated with multiple cancers. We will conduct the largest ever study to find new genes for endometrial cancer, the most common gynaecological cancer. Our unique approach will examine >11million markers across the genome, some specifically in regions known to be important for other cancers. Findings will be used for risk prediction models ....Studies investigating thousands of genetic markers have revolutionised our understanding of genes involved in cancer, and shown that a single gene can be associated with multiple cancers. We will conduct the largest ever study to find new genes for endometrial cancer, the most common gynaecological cancer. Our unique approach will examine >11million markers across the genome, some specifically in regions known to be important for other cancers. Findings will be used for risk prediction models.Read moreRead less
Collaborative Australian Renal Cell Carcinoma Epidemiology Study (CARES)
Funder
National Health and Medical Research Council
Funding Amount
$1,677,048.00
Summary
The objective of this project is to increase our knowledge of the causes of renal cell carcinoma, a relatively common, yet understudied, cancer and use this new knowledge to develop a risk prediction tool to provide a rational basis for risk counselling. The proposed project will establish a biobank and generate a research platform that, beyond the duration of the project, will allow us to identify diagnostic and prognostic biomarkers, and therapeutic targets.
The Epidemiology Of Multiple Myeloma In Australia (EMMA)
Funder
National Health and Medical Research Council
Funding Amount
$1,525,729.00
Summary
In Australia, over 1,000 people are diagnosed with multiple myeloma annually. Our proposal aims to identify possible environmental and genetic causes of this serious disease. People diagnosed with myeloma, and their family members, will provide detailed personal and family histories. We plan to investigate the role of sun exposure, body size and obesity, dietary factors and pesticides as well as a large range of genetic variants. The 5-year study will be conducted in Victoria and NSW.
Clostridium Difficile: Assessing The Risks To Australia Of An Emerging Healthcare-related Pathogen
Funder
National Health and Medical Research Council
Funding Amount
$1,180,256.00
Summary
Clostridium difficile is a bacterium that causes inflammation of the large bowel that can lead to surgical removal of the bowel or death. In North America and Europe, an international epidemic strain has caused large outbreaks of severe, fatal disease. In 2009, this strain was identified for the first time in Perth, Australia. We will investigate strains currently present in Brisbane and Perth and risk of outbreaks occurring from imported and local strains.
A Population-based Family Study Of Follicular Lymphoma
Funder
National Health and Medical Research Council
Funding Amount
$1,703,070.00
Summary
Annually more than 900 Australians are diagnosed with follicular lymphoma. The proposed research aims identify the environmental and genetic causes of this serious blood cancer. People diagnosed with lymphoma, and a family member, will provide detailed personal and family histories, and a blood sample. Exposure to specific chemicals, types of work, sun exposure, and body size are some of the factors the study will examine. The 5-year study will be conducted in NSW, ACT and Victoria.
Case-Control Study Of Genetic And Environmental Risk Factors For Pancreatic Carcinoma
Funder
National Health and Medical Research Council
Funding Amount
$1,003,411.00
Summary
Pancreatic carcinoma is the fourth most common cause of cancer death in developed countries, and is approximately sixty percent more common in men than in women. In Australia approximately 1800 people are diagnosed with pancreatic cancer each year and there are a similar number of deaths. The five-year survival is less than five percent, and the majority of patients die within the first year. Surgery is frequently not possible due to the advanced stage of disease at diagnosis, and chemotherapy i ....Pancreatic carcinoma is the fourth most common cause of cancer death in developed countries, and is approximately sixty percent more common in men than in women. In Australia approximately 1800 people are diagnosed with pancreatic cancer each year and there are a similar number of deaths. The five-year survival is less than five percent, and the majority of patients die within the first year. Surgery is frequently not possible due to the advanced stage of disease at diagnosis, and chemotherapy is largely ineffective. A better understanding of the causes of pancreatic cancer is essential in order to develop strategies to prevent this lethal cancer. Currently the causes of pancreatic cancer are poorly understood. Family history and smoking probably account for approximately 30% of cases, but for the remainder the cause is unknown. This study will assess a new hypothesis, namely that too much acid in the stomach possibly caused by infection with a bacterial organism, could increase the risk of pancreatic cancer. We will include people who are diagnosed with cancer of the pancreas (cases), and match these to people selected from the electoral roll who have not ever been diagnosed with pancreatic cancer (controls). Participants will be asked a series of detailed questions about their diet, smoking, occupation and medical history. We will collect blood to look for antibodies to the bacteria and to examine specific genes, and we will compare all these factors in cases and controls. This is one of the first large studies of pancreatic cancer in Australia and we will take an integrated approach to examining interactions between genetics and exposure to environmental factors.Read moreRead less